Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.68 |
| ▸ | MEN1 | O00255 | 3/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.68 |
| ▸ | HPGD | P15428 | 3/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.68 |
| ▸ | MAPT | P10636 | 1/20 | 0.68 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.68 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.58 |
| ▸ | HEXA | P06865 | 1/20 | 0.54 |
| ▸ | HEXB | P07686 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19886995 | 0.97 | KDM4E (0.72) | KDM4EALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL16057586 | 0.85 | CA12 (0.66) | KDM4EALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL29831664 | 0.85 | CA12 (0.66) | KDM4EALDH1A1MEN1KMT2AHPGD | |
| Alrestatin SCHEMBL31745280 | 0.82 | KDM4E (1.00) | KDM4EALDH1A1MEN1KMT2AHPGD | |
| Alrestatin SCHEMBL450743 | 0.82 | KDM4E (1.00) | KDM4EALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL25583414 | 0.81 | KDM4E (0.69) | KDM4EALDH1A1MEN1KMT2AHPGD | |
| Alrestatin SCHEMBL636522 | 0.81 | KDM4E (0.97) | KDM4EALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL19891055 | 0.79 | KDM4E (0.54) | KDM4EALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL19891133 | 0.79 | KDM4E (0.51) | KDM4EALDH1A1MEN1KMT2AHPGD | |
| SCHEMBL19891009 | 0.78 | ACE (0.48) | KDM4EALDH1A1MEN1KMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10725046-B2 | Water-soluble peptide fluorescence material | NATIONAL CHIAO TUNG UNIVERSITY (TW) | 2020-07-28 | — | — | US | disclosed |
| US-20190120849-A1 | WATER-SOLUBLE PEPTIDE FLUORESCENCE MATERIAL | NATIONAL CHIAO TUNG UNIVERSITY (TW) | 2019-04-25 | — | — | US | disclosed |
| US-10222381-B2 | Water-soluble peptide fluorescence material | NATIONAL CHIAO TUNG UNIVERSITY (TW) | 2019-03-05 | — | — | US | disclosed |
| US-20180052170-A1 | WATER-SOLUBLE PEPTIDE FLUORESCENCE MATERIAL | NATIONAL CHIAO TUNG UNIVERSITY (TW) | 2018-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180052170-A1 | WATER-SOLUBLE PEPTIDE FLUORESCENCE MATERIAL | OGFRL1, NGLY1, SLC7A5 | KDM4E 4877/4885ALDH1A1 2983/4885MEN1 2908/4885 |
| US-20190120849-A1 | WATER-SOLUBLE PEPTIDE FLUORESCENCE MATERIAL | OGFRL1, NGLY1, ARGLU1 | KDM4E 4872/4885ALDH1A1 2953/4885MEN1 3022/4885 |
| US-10222381-B2 | Water-soluble peptide fluorescence material | OGFRL1, NGLY1, SLC7A5 | KDM4E 4877/4885ALDH1A1 2983/4885MEN1 2908/4885 |
| US-10725046-B2 | Water-soluble peptide fluorescence material | OGFRL1, NGLY1, ARGLU1 | KDM4E 4872/4885ALDH1A1 2953/4885MEN1 3022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.